Sign in
4

Changes in Ownership

Denali Therapeutics Inc. Filed Acc 0001209191-19-059343

COO and Secretary sold 7,500 shares at an average $18.00 ($135,017)

  • COO and Secretary acquired 3,832 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Schuth Alexander O. COO and Secretary 2019-12-03 Sale −1,012 $18.01 $18,226 583,366 I
Schuth Alexander O. COO and Secretary 2019-12-03 Option exercise +711 $5.28 $3,754 26,550 D
Schuth Alexander O. COO and Secretary 2019-12-03 Sale −711 $18.01 $12,805 25,839 D
Schuth Alexander O. COO and Secretary 2019-12-04 Sale −2,656 $18.00 $47,808 580,710 I
Schuth Alexander O. COO and Secretary 2019-12-04 Option exercise +3,121 $5.28 $16,479 28,960 D
Schuth Alexander O. COO and Secretary 2019-12-04 Sale −3,121 $18.00 $56,178 25,839 D
Derivatives
Schuth Alexander O. COO and Secretary 2019-12-03 Option exercise · Stock Option (right to buy) −711 112,058 D
Schuth Alexander O. COO and Secretary 2019-12-04 Option exercise · Stock Option (right to buy) −3,121 108,937 D
Open-market sales · 7,500 sh · avg $18.00 · $135,017
Loading xslF345X03/doc4.xml…